National Bank of Canada
ATYR

National Bank of Canada’s aTyr Pharma ATYR Stock Holding History

National Bank of Canada’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-358
Closed -$1.3K – 3206
2024
Q4 		$1.3K Hold
358
– – ﹤0.01% 2623
2024
Q3 		$630 Buy
+358
New +$651 ﹤0.01% 2465

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

National Bank of Canada's ATYR Position: Q1 2025 in Review

National Bank of Canada sold out of aTyr Pharma (ATYR) in Q1 2025, closing a stake of 358 shares — an estimated $1.3K sold.

National Bank of Canada first reported a position in ATYR in Q3 2024 and held it in 2 quarters. The position peaked at $1.3K in Q4 2024. 87 funds tracked by Wall St. Rank hold ATYR as of Q1 2025.

  • National Bank of Canada reported no remaining aTyr Pharma position as of Q1 2025 after selling out during the quarter.
  • National Bank of Canada sold 358 aTyr Pharma shares in Q1 2025, an estimated $1.3K.
  • National Bank of Canada first reported a position in aTyr Pharma in Q3 2024 and held it in 2 quarters.
  • National Bank of Canada's aTyr Pharma position peaked at $1.3K in Q4 2024.
  • 87 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2025.

Based on National Bank of Canada's 13F filing for Q1 2025, filed 12 May 2025.